Radient Pharmaceuticals receives NYSE Amex non-compliance notice

Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: RPC) today announced it has received notice from the NYSE Amex that the Company is not in compliance with the continued listing standard in Section 1003(a)(iv) of the Exchange's Company Guide. The Company has until January 22, 2010 to submit a plan to regain compliance by June 23, 2010. If the Company does not submit a plan or if the plan is not accepted by the Exchange, or if our plan is accepted but we fail to make progress consistent with our plan, or we are not in compliance by June 23, 2010, the Company would be subject to delisting procedures.